First generation bone void fillers had good compression strength, but lacked good handling characteristics. Additionally, they were not ideal in terms of flexural strength and fracture toughness.
Cranio Sculpt™ overcomes the limitations of past bone void fillers and provides the surgeon greater control of their ideal augmentation.
Cranio Sculpt™ is similar in composition to the mineral phase of bone. A calcium phosphate starting powder reacts with diluted sodium silicate liquid, and undergoes a non-exothermic chemical reaction to form low crystalline hydroxyapatite, which hardens in vivo to create an osteoconductive scaffold.
Histology analysis demonstrated that Cranio Sculpt™ is highly biocompatible and osteoconductive. Histological sections were examined following four weeks and six months in vivo and showed extensive bone apposition with no adverse tissue reaction. Normal bone remodeling by localized osteoclastic, cell mediated resorption coupled with new bone formation within the implanted area was a consistent finding in areas implanted with Cranio Sculpt™.
Yetkinler, Delaney, Constanz, "An In Vivo Evaluation of Two Calcium Phosphate Cements", Skeletal Kinetics LLC, Cupertino, CA
The information presented is intended to demonstrate a KLS Martin LP product. Please refer to the for the full list of indications, contraindications, warnings, precautions, and sterilization information. Always refer to the before using any KLS Martin LP product. Surgeons must always rely on their own clinical judgment when deciding which products and techniques to use with their patients.
KLS Martin® LP, a member of the KLS Martin Group
brochure & technique